(Total Views: 78)
Posted On: 05/21/2021 12:45:47 PM
Post# of 85568
$BLUE News Article - bluebird bio Receives Positive CHMP Opinion for SKYSONA(TM) (elivaldogene autotemcel, Lenti-D(TM)) Gene Therapy for Patients Less Than 18 Years of Age with Early Cerebral Adrenoleukodystrophy (CALD) https://marketwirenews.com/news-releases/blue...03923.html
(0)
(0)
My Twitter: WhyteStocks
